Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB
- PMID: 19191632
- DOI: 10.1086/597010
Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB
Abstract
Multidrug-resistant tuberculosis (TB) strains resistant to the fluoroquinolones and streptomycin but susceptible to second-line injection treatment would not be defined as extensively drug-resistant TB. In a cohort of 174 patients with multidrug-resistant TB, we demonstrated that 12 patients with multidrug-resistant TB strains resistant to the fluoroquinolones and streptomycin had significantly better initial and long-term outcomes, compared with 10 patients with extensively drug-resistant TB.
Comment in
-
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment.Clin Infect Dis. 2009 Jul 15;49(2):315-6; author reply 317. doi: 10.1086/600060. Clin Infect Dis. 2009. PMID: 19538069 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
